USFDA gives exception to Glenmark Pharma to supply pneumonia drug from Baddi facility
Glenmark Pharma Share Price NSE: Glenmark Pharmaceuticals Ltd on Friday said the US health regulator has provided an exception, enabling it to supply Atovaquone oral suspension to the US market from its Baddi facility, which has been under an import alert.
Glenmark Pharma Share Price NSE: Glenmark Pharmaceuticals Ltd on Friday said the US health regulator has provided an exception, enabling it to supply Atovaquone oral suspension to the US market from its Baddi facility, which has been under an import alert.
In a regulatory filing, Glenmark said, "...Due to medical necessity and potential drug shortage expectations, the USFDA has provided an exception, which enables the Company to supply Atovaquone Oral Suspension USP 750mg/5ml to the US market".
The exception will be reconsidered if the market conditions change, it added.
Atovaquone oral suspension is indicated for the treatment of mild to moderate Pneumocystis pneumonia.
In October last year, Glenmark had stated that the US Food and Drug Administration has put its manufacturing plant at Baddi under import alert 66-40, with drugs produced at the unit can be detained without physical examination.
As per the USFDA, import alert 66-40 implies detention without physical examination of drugs from firms, which have not met drug GMPs.
The USFDA inspected the facility in June 2022 and subsequently placed it under "Official Action Indicated" status, implying that the regulator may withhold approval of any pending product applications or supplements filed from such facility till the outstanding observations related to non-compliance with manufacturing norms laid down by it.
"The company will engage with the agency to resolve the import alert at the earliest," Glenmark said in the filing.
Glenmark Pharma Share Price NSE
Shares of Glenmark Pharmaceuticals Ltd, NSE: GLENMARK on Friday ended at Rs 382.20, down by 4.17 per cent.
Glenmark Pharma Share Price NSE
Glenmark Pharma shares have yielded around 22 per cent return to investors in last one year. The stock's 52-week range is Rs 505.50 - Rs 348.50. At current levels, the company has a market cap of Rs 10.78 thousand crore.
Click Here For Latest Updates On Stock Market | Zee Business Live
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years
Top Gold ETF vs Top Large Cap Mutual Fund 10-year Return Calculator: Which has given higher return on Rs 11 lakh investment; see calculations
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus
Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths
05:01 PM IST